HistoSonics announced that its Edison histotripsy system for noninvasively destroying liver tumors has secured early U.K.

Abbott published findings from the AVEIR DR i2i study evaluating the company's novel dual-chamber leadless pacemaker (LP) ...

Vivani Medical (Nasdaq:VANI) announced that it filed a Form 10 registration statement with the SEC to spin off its ...

Reuters reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the ...

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

CoreMap announced that it received FDA investigational device exemption (IDE) to extend its electrophysiology (EP) mapping ...

The Financial Times reported yesterday that a duo of private equity firms approached Hologic (Nasdaq: HOLX) about a potential ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced results from a study of its Monarch platform for robotic bronchoscopy ...

Inspire Medical Systems (NYSE: INSP) announced that it recently launched the EuroStim registry evaluating its technology in ...

Distalmotion received FDA 510(k) clearance for the use of its Dexter surgical robot in adult cholecystectomy (gallbladder ...

BD (NYSE: BDX) announced today that it plans to initiate a patient data registry for its Rotarex atherectomy system.

Empatica announced today that it received CE mark approval for its EpiMonitor epilepsy monitoring solution. EpiMonitor, a ...